Ron Bentsur
2014 - Keryx Biopharmaceuticals
In 2014, Ron Bentsur earned a total compensation of $9.2M as Former Chief Executive Officer at Keryx Biopharmaceuticals, a 81% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $344,500 |
---|---|
Option Awards | $639,113 |
Salary | $491,667 |
Stock Awards | $7,686,097 |
Total | $9,161,377 |
Bentsur received $7.7M in stock awards, accounting for 84% of the total pay in 2014.
Bentsur also received $344.5K in non-equity incentive plan, $639.1K in option awards and $491.7K in salary.
Rankings
In 2014, Ron Bentsur's compensation ranked 602nd out of 13,032 executives tracked by ExecPay. In other words, Bentsur earned more than 95.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 602 | 95th |
Manufacturing | 213 | 96th |
Chemicals And Allied Products | 68 | 96th |
Drugs | 52 | 96th |
Pharmaceutical Preparations | 49 | 95th |
Bentsur's colleagues
We found two more compensation records of executives who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2014.